Department of Oncology, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China.
Department of Intervention, The Fourth Affiliated Hospital of China Medical University, No. 4, Chongshan East Road, Huanggu District, Shenyang, 110032, Liaoning, People's Republic of China.
J Transl Med. 2023 Feb 10;21(1):105. doi: 10.1186/s12967-023-03894-1.
The role of microRNA (miRNA) in modulating the function of cancer stem cells through diverse signaling pathway has been evidenced. We here identified a role of microRNA (miRNA) family, specifically miR-148/152, in gastric cancer and delineated its functional effects on gastric cancer stem cells.
Bioinformatics analysis was conducted to analyze expression of integrin α5 (ITGA5) which was verified through expression determination in clinical tissue samples. Next, the upstream regulatory factors of ITGA5 were determined. CD44EpCAM (high) cells sorted from AGS cells subjected to gain-of-function experiments, followed by evaluation of their capacity of colony formation, generation of tumorosphere, cell migration and viability in vitro and xenograft tumor formation in vivo.
ITGA5 was elevated in gastric cancer tissues and confirmed as a target gene of the miR-148/152 family members. The miR-148/152 family members were downregulated in gastric cancer tissues and cells. Decreased expression of miR-148/152 family members was also detected in gastric cancer stem cells. However, the raised expression led to reduced colony formation, tumorosphere, cell migration, cell viability, and drug resistance of CD44+EpCAM (high) AGS cells in vitro, and tumorigenesis in vitro. ITGA5 overexpression reversed the effect of the miR-148/152 family members.
This study demonstrates that the miR-148/152 family members may prevent gastric cancer stem cell-like properties by targeting ITGA5, which can serve as an appealing target for gastric cancer treatment.
已有证据表明,微小 RNA(miRNA)在通过多种信号通路调节癌症干细胞功能方面发挥作用。我们在此确定了 miRNA 家族(特别是 miR-148/152)在胃癌中的作用,并描绘了其对胃癌干细胞的功能影响。
通过对临床组织样本中 ITGA5 表达的测定,进行生物信息学分析。接下来,确定了 ITGA5 的上游调节因子。AGS 细胞中 CD44+EpCAM(高)细胞经功能获得实验后,体外评估其集落形成、肿瘤球生成、细胞迁移和活力以及体内异种移植肿瘤形成能力。
ITGA5 在胃癌组织中上调,并被确认为 miR-148/152 家族成员的靶基因。miR-148/152 家族成员在胃癌组织和细胞中下调。胃癌干细胞中也检测到 miR-148/152 家族成员表达降低。然而,表达升高导致 CD44+EpCAM(高)AGS 细胞体外集落形成、肿瘤球生成、细胞迁移、细胞活力和耐药性降低,体外致瘤性降低。ITGA5 过表达逆转了 miR-148/152 家族成员的作用。
本研究表明,miR-148/152 家族成员可能通过靶向 ITGA5 来防止胃癌干细胞样特性,这可为胃癌治疗提供有吸引力的靶点。